» Articles » PMID: 15170211

Acute Myeloid Leukemia Originates from a Hierarchy of Leukemic Stem Cell Classes That Differ in Self-renewal Capacity

Overview
Journal Nat Immunol
Date 2004 Jun 1
PMID 15170211
Citations 352
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidence suggests cancer stem cells sustain neoplasms; however, little is understood of the normal cell initially targeted and the resultant cancer stem cells. We show here, by tracking individual human leukemia stem cells (LSCs) in nonobese diabetic-severe combined immunodeficiency mice serially transplanted with acute myeloid leukemia cells, that LSCs are not functionally homogeneous but, like the normal hematopoietic stem cell (HSC) compartment, comprise distinct hierarchically arranged LSC classes. Distinct LSC fates derived from heterogeneous self-renewal potential. Some LSCs emerged only in recipients of serial transplantation, indicating they divided rarely and underwent self-renewal rather than commitment after cell division within primary recipients. Heterogeneity in LSC self-renewal potential supports the hypothesis that they derive from normal HSCs. Furthermore, normal developmental processes are not completely abolished during leukemogenesis. The existence of multiple stem cell classes shows the need for LSC-targeted therapies.

Citing Articles

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

Rubino V, Huppi M, Hopner S, Tortola L, Schnuriger N, Legenne H Cell Rep Med. 2024; 5(11):101826.

PMID: 39536753 PMC: 11604404. DOI: 10.1016/j.xcrm.2024.101826.


AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients.

Jung S, Nelde A, Maringer Y, Denk M, Zieschang L, Kammer C Front Oncol. 2024; 14:1458449.

PMID: 39469638 PMC: 11513396. DOI: 10.3389/fonc.2024.1458449.


Caspase-Activated DNase localizes to cancer causing translocation breakpoints during cell differentiation.

Alsowaida D, Larsen B, Hachmer S, Azimi M, Arezza E, Brunette S bioRxiv. 2024; .

PMID: 39386486 PMC: 11463586. DOI: 10.1101/2024.09.24.614809.


MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia.

Wu K, Li Y, Nie B, Guo C, Ma X, Li L Int J Oncol. 2024; 65(5).

PMID: 39329212 PMC: 11436260. DOI: 10.3892/ijo.2024.5699.


RNA binding protein-directed control of leukemic stem cell evolution and function.

Joshi P, Keyvani Chahi A, Liu L, Moreira S, Vujovic A, Hope K Hemasphere. 2024; 8(8):e116.

PMID: 39175825 PMC: 11339706. DOI: 10.1002/hem3.116.